ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.87974
-0.04%
Brent Oil
83.355
-0.14%
Bitcoin
63,446.40
0.44%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Homology Medicines Inc (FIXX)

  7. Homology Medicines Inc (FIXX) Noticias

FIXX

Homology Medicines (FIXX)

Homology Medicines Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FIXX
FechaHoraFuenteTítuloSímboloCompañía
18/03/202415:30GlobeNewswire Inc.Homology Medicines Declares Distribution to Common StockholdersNASDAQ:FIXXHomology Medicines Inc
11/03/202406:37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
11/03/202406:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
14/02/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FIXXHomology Medicines Inc
13/02/202409:11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FIXXHomology Medicines Inc
05/01/202416:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
03/01/202415:08GlobeNewswire Inc.Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyNASDAQ:FIXXHomology Medicines Inc
11/12/202315:15Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FIXXHomology Medicines Inc
17/11/202315:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
16/11/202306:05GlobeNewswire Inc.Q32 Bio and Homology Medicines Announce Merger AgreementNASDAQ:FIXXHomology Medicines Inc
14/11/202315:33GlobeNewswire Inc.Homology Medicines Reports Third Quarter 2023 Financial ResultsNASDAQ:FIXXHomology Medicines Inc
14/08/202315:05GlobeNewswire Inc.Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
14/08/202315:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FIXXHomology Medicines Inc
27/07/202315:05GlobeNewswire Inc.Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUNASDAQ:FIXXHomology Medicines Inc
27/07/202315:01GlobeNewswire Inc.Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKUNASDAQ:FIXXHomology Medicines Inc
15/06/202318:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FIXXHomology Medicines Inc
14/06/202315:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FIXXHomology Medicines Inc
16/05/202307:00GlobeNewswire Inc.Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
11/05/202315:05GlobeNewswire Inc.Homology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
11/05/202315:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FIXXHomology Medicines Inc
03/05/202306:30GlobeNewswire Inc.Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
28/04/202316:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FIXXHomology Medicines Inc
28/04/202315:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FIXXHomology Medicines Inc
28/04/202315:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FIXXHomology Medicines Inc
20/03/202305:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FIXXHomology Medicines Inc
16/03/202316:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FIXXHomology Medicines Inc
15/03/202315:01GlobeNewswire Inc.Homology Medicines Announces Presentations on Design of Ongoing Gene Editing and Gene Therapy Trials for PKU and Hunter Syndrome at ACMG Annual Clinical Genetics MeetingNASDAQ:FIXXHomology Medicines Inc
09/03/202315:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FIXXHomology Medicines Inc
09/03/202315:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FIXXHomology Medicines Inc
09/03/202315:05GlobeNewswire Inc.Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:FIXX

Su Consulta Reciente

COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
NYSE
NKE
Nike
USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
USI
USTECH100
US Tech 100
FX
EURUSD
Euro vs US Dollar
NYSE
MCD
McDonalds
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
CCOM
US30
US 30
NYSE
CVX
Chevron
CCOM
SILVER
SILVER
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados